Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products primarily to home health care market for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.
Industry, Sector and Symbol
Stock Exchange NYSEAMERICAN
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:ELMD
Previous SymbolNYSEMKT:ELMD
CUSIPN/A
Phone+1-952-7589299
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees132
Outstanding Shares8,350,000
Market Cap$0.00
OptionableNot Optionable
Electromed (NYSEAMERICAN:ELMD) Frequently Asked Questions
What is Electromed's stock symbol?
Electromed trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ELMD."
How were Electromed's earnings last quarter?
Electromed, Inc. (NYSEAMERICAN:ELMD) released its quarterly earnings results on Tuesday, November, 13th. The medical equipment provider reported $0.02 earnings per share for the quarter. The medical equipment provider had revenue of $7.28 million for the quarter. View Electromed's Earnings History.
When is Electromed's next earnings date?
Has Electromed been receiving favorable news coverage?
Media coverage about ELMD stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Electromed earned a coverage optimism score of 1.0 on InfoTrie's scale. They also gave news coverage about the medical equipment provider a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
Who are some of Electromed's key competitors?
Some companies that are related to Electromed include Activecare (ACAR), Advanced Oncotherapy (AVO), Airware Labs (AIRW), Anteo Diagnostics (ADO), Aurora Spine (ASG), Avacta Group (AVCT), Azure Healthcare (AZV), Biosig Technologies (BSGM), Cannabix Technologies (BLOZF), Cochlear (COH), ConvaTec Group (CTEC), Creo Medical Group (CREO), Draegerwerk AG & Co KGaA (DRW3), Ellex Medical Lasers (ELXMF) and Fisher & Paykel Healthcare (FPH).
Who are Electromed's key executives?
Electromed's management team includes the folowing people:
- Ms. Kathleen S. Skarvan, CEO, Pres & Director (Age 62)
- Mr. Jeremy T. Brock CPA, CFO, Principal Accounting Officer & Financial Controller (Age 39)
- Mr. John Kowalczyk, VP of Sales & Marketing
- Mr. William J. George J.D., Sec. (Age 69)
- Ms. Kathryn Thompson, VP of Reimbursement
Who are Electromed's major shareholders?
Electromed's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Tocqueville Asset Management L.P. (4.50%), Quantum Capital Management (0.88%) and Renaissance Technologies LLC (0.75%). Company insiders that own Electromed stock include Red Oak Partners, Llc and Stephen H Craney. View Institutional Ownership Trends for Electromed.
Which institutional investors are selling Electromed stock?
Which institutional investors are buying Electromed stock?
How do I buy shares of Electromed?
Shares of ELMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Electromed's stock price today?
One share of ELMD stock can currently be purchased for approximately $5.68.
What is Electromed's official website?
How can I contact Electromed?
Electromed's mailing address is 500 6th Ave NW, NEW PRAGUE, MN 56071-1134, United States. The medical equipment provider can be reached via phone at +1-952-7589299.
MarketBeat Community Rating for Electromed (NYSEAMERICAN ELMD)
MarketBeat's community ratings are surveys of what our community members think about Electromed and other stocks. Vote "Outperform" if you believe ELMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
